Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling
Erdogan Taskesen(Amsterdam Neuroscience), Ruud Delwel(Erasmus MC Cancer Institute), Marije Havermans(Oncode Institute), Ari Melnick(Cornell University), Remco M. Hoogenboezem(Erasmus MC Cancer Institute), Yvette van Norden(Erasmus MC Cancer Institute), Bob Löwenberg(Unknown), Marcel Reinders(Leiden University), Mathijs A. Sanders, Eric M. Bindels(Erasmus MC Cancer Institute), Peter J.M. Valk(Erasmus MC Cancer Institute), Kirsten van Lom(Rotterdam University of Applied Sciences), María E. Figueroa(University of Miami)
Cited by 59
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k